Evolving criteria for group E retinoblastoma (2): Impact on outcomes. Singh A, Raval V, Sedaghat A, Kaliki S, et al. Can J Ophthalmol 2024 May 31:S0008-4182(24)00139.

Read + Share

Amedeo Smart

Independent Medical Education

Singh A, Raval V, Sedaghat A, Kaliki S, et al. Evolving criteria for group E retinoblastoma (2): Impact on outcomes. Can J Ophthalmol 2024 May 31:S0008-4182(24)00139.
PMID: 38830602